The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Sep. 20, 2022

Filed:

Jul. 06, 2020
Applicants:

The Translational Genomics Research Institute, Phoenix, AZ (US);

Arizona Board of Regents on Behalf of Northern Arizona University, Flagstaff, AZ (US);

Inventors:

David Engelthaler, Flagstaff, AZ (US);

Elizabeth Driebe, Flagstaff, AZ (US);

Hongwei “Holly” Yin, Phoenix, AZ (US);

Michael Valentine, Flagstaff, AZ (US);

Donald Chow, Phoenix, AZ (US);

Jolene Bowers, Flagstaff, AZ (US);

Paul Keim, Flagstaff, AZ (US);

Bridget Barker, Flagstaff, AZ (US);

Attorneys:
Primary Examiner:
Int. Cl.
CPC ...
A61K 31/41 (2006.01); A61K 31/135 (2006.01); A61K 38/13 (2006.01); A61K 31/7135 (2006.01); A61K 31/58 (2006.01); A61K 31/5377 (2006.01); A61K 31/5415 (2006.01); A61K 31/4196 (2006.01); A61K 31/496 (2006.01); A61K 31/495 (2006.01); A61K 45/06 (2006.01); A61K 31/138 (2006.01); A61K 31/277 (2006.01); A61K 31/353 (2006.01); A61K 31/404 (2006.01); A61K 31/4174 (2006.01); A61K 31/428 (2006.01); A61K 31/4741 (2006.01); A61K 31/609 (2006.01);
U.S. Cl.
CPC ...
A61K 38/13 (2013.01); A61K 31/138 (2013.01); A61K 31/277 (2013.01); A61K 31/353 (2013.01); A61K 31/404 (2013.01); A61K 31/4174 (2013.01); A61K 31/4196 (2013.01); A61K 31/428 (2013.01); A61K 31/4741 (2013.01); A61K 31/495 (2013.01); A61K 31/496 (2013.01); A61K 31/5377 (2013.01); A61K 31/5415 (2013.01); A61K 31/58 (2013.01); A61K 31/609 (2013.01); A61K 31/7135 (2013.01); A61K 45/06 (2013.01);
Abstract

The present invention comprises methods of treating an infection using a pharmaceutical composition comprising an active ingredient selected from Table 1. In some aspects, the infection can be caused by one or more pathogens, including fungal pathogens. For example, the infection may be Valley Fever.


Find Patent Forward Citations

Loading…